Compounded tirzepatide is legal under FDA section 503A only when the brand product is on the FDA shortage list, when a patient has a documented allergy to a brand component, or when the dose required is not commercially available
2 The relationship between diabetes and obesity is a two-way street: Obesity leads to a heightened risk of diabetes, and the presence of diabetes in patients with obesity contributes to disease progression and cardiovascular complications
However, it's worth noting that in clinical trials for tirzepatide for weight management, alopecia was reported more frequently than with placebo
But for those who do, consider reducing your dose, which will help ease and reduce any side effects
Tissue-Resident Macrophage Ontogeny Homeost Immun
She was prescreened for a clinical trial with barzolvolimab